# Histotripsy: Changing How We Treat Cancer

Page: https://stenobird.com/podcast/the-goop-podcast-490260/histotripsy-changing-how-we-treat-cancer
Text version: https://stenobird.com/podcast/the-goop-podcast-490260/histotripsy-changing-how-we-treat-cancer.md
Podcast: [the goop podcast](https://stenobird.com/podcast/the-goop-podcast-490260)
Published: 2026-02-17T08:01:00+00:00
Episode link: https://pdst.fm/e/traffic.megaphone.fm/CAD2261391529.mp3?updated=1771955006
Audio file: https://pdst.fm/e/traffic.megaphone.fm/CAD2261391529.mp3?updated=1771955006
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-goop-podcast-490260/episodes/histotripsy-changing-how-we-treat-cancer
Duration seconds: 3138

## Resource

Gwyneth sits down with Mike Blue—CEO of HistoSonics—to explore histotripsy, a breakthrough noninvasive ultrasound technology designed to destroy tumors without surgery, chemotherapy, or radiation. He shares the 25-year journey behind the technology, the patients already benefiting from the FDA-cleared treatment for liver tumors, and how this approach could challenge decades of invasive cancer care—signaling a profound shift toward safer, more precise treatment. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-goop-podcast-490260/episodes/histotripsy-changing-how-we-treat-cancer/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-goop-podcast-490260/histotripsy-changing-how-we-treat-cancer.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.